Adherence to Repeat Fecal Occult Blood Testing in an Urban Community Health Center Network
- First Online:
- 274 Downloads
Annual fecal occult blood testing (FOBT) has the potential to reduce colorectal cancer mortality, but in practice it is challenging to complete FOBT every year. Repeat FOBT adherence may be especially low in community health center (CHC) settings, where many patients face barriers to annual FOBT completion. We conducted a retrospective cohort analysis to investigate adherence to annual FOBT in an urban CHC network that serves a predominantly Spanish-speaking, uninsured adult patient population. This study used data from the two-year period between January 2010 and December 2011, and included adults aged 50–74 who completed a screening FOBT with a negative result during the first 6 months of 2010. We examined whether each patient completed a second FOBT between 9 and 18 months after the initial negative FOBT, and tested whether repeat FOBT adherence was associated with patient characteristics or the number of clinic visits after the initial negative FOBT. Only 69 of 281 included patients completed repeat FOBT (24.6 % adherence), and none of 62 patients (0 %) with 0 clinic visits completed repeat FOBT. We detected no significant differences in adherence by age, sex, preferred language, insurance status, or number of chronic conditions. In multivariable regression, the adjusted relative risk of repeat FOBT was 1.66 (95 % CI 1.09–2.54; p = 0.02) among patients with 3 or more clinic visits (referent: patients with 1–2 visits). The observed low rate of adherence greatly diminishes the effectiveness of FOBT in reducing CRC mortality. Findings demonstrate the need for systems-based interventions that increase adherence without requiring face-to-face encounters.
KeywordsColorectal cancer Cancer screening Adherence Preventive care Disparities
- 2.Zauber, A. G., Lansdorp-Vogelaar, I., Knudsen, A. B., Wilschut, J., van Ballegooijen, M., & Kuntz, K. M. (2008). Evaluating test strategies for colorectal cancer screening: A decision analysis for the U.S. Preventive Services Task Force. Annals of Internal Medicine, 149(9), 659–669.PubMedCrossRefGoogle Scholar
- 3.U.S. Preventive Services Task Force. (2008). Screening for colorectal cancer: Clinical summary of U.S. preventive task force recommendation. http://www.uspreventiveservicestaskforce.org/uspstf08/colocancer/colcancs.pdf. Accessed 28 Jan 2013.
- 17.The Dartmouth Atlas of Health Care. (2008). List of ICD-9-CM codes by chronic disease category. Nine chronic conditions used in The Dartmouth Atlas of Health Care 2008. http://www.dartmouthatlas.org/downloads/methods/chronic_disease_codes_2008.pdf. Accessed 28 Jan 2013.
- 22.Committee on Quality of HealthCare in America. (2001). Crossing the quality chasm: A new health system for the twenty-first century. Washington, DC: Institute of Medicine.Google Scholar
- 26.Federici, A., Giorgi Rossi, P., Borgia, P., Bartolozzi, F., Farchi, S., & Gausticchi, G. (2005). The immunochemical faecal occult blood test leads to higher compliance than the guaiac for colorectal cancer screening programmes: A cluster randomized controlled trial. Journal of Medical Screening, 12(2), 83–88.PubMedCrossRefGoogle Scholar
- 27.Hoffman, R. M., Steel, S., Yee, E. F., Massie, L., Schrader, R. M., & Murata, G. H. (2010). Colorectal cancer screening adherence is higher with fecal immunochemical tests than guaiac-based fecal occult blood tests: A randomized, controlled trial. Preventive Medicine, 50(5–6), 297–299.PubMedCrossRefGoogle Scholar
- 28.Health Resources and Resources Administration. (2012). Approved uniform data system changes for 2012: Program assistance letter 2012–03. http://bphc.hrsa.gov/policiesregulations/policies/pdfs/pal201203.pdf. Accessed 30 Jan 2013.